• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

ImmuONE

To add a bio or update company history, please click update information.

News from ImmuONE

    ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testingImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
    ImmuONE
    13 Mar 2025

    ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing

    ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.

ImmuONE
  • Life Sciences
  • Milton Keynes, United Kingdom
  • £600k
  • immuone.com
  • Update Information

More venture news

  • NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
    NunaBio
    5 May 2026

    NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale

    EquityLife Sciences
  • Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells
    Cytospire Therapeutics
    5 May 2026

    Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells

    Series ALife Sciences
  • BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space
    BioOrbit
    30 Apr 2026

    BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn